|
1
|
Brodeur GM: Neuroblastoma: biological
insights into a clinical enigma. Nat Rev Cancer. 3:203–216. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Beckwith JB and Martin RF: Observations on
the histopathology of neuroblastomas. J Pediatr Surg. 3:106–110.
1968. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhu S, Yan X, Xiang Z, Ding HF and Cui H:
Leflunomide reduces proliferation and induces apoptosis in
neuroblastoma cells in vitro and in vivo. PLoS One. 8:e715552013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li T, Cui ZB, Ke XX, et al: Essential role
for p53 and caspase-9 in DNA damaging drug-induced apoptosis in
neuroblastoma IMR32 cells. DNA Cell Biol. 30:1045–1050. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li T, Wang L, Ke XX, et al: DNA-damaging
drug-induced apoptosis sensitized by N-myc in neuroblastoma cells.
Cell Biol Int. 36:331–337. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Askin FB and Perlman EJ: Neuroblastoma and
peripheral neuroectodermal tumors. Am J Clin Pathol. 109:S23–S30.
1998.PubMed/NCBI
|
|
7
|
Shah S and Ravindranath Y: Neuroblastoma.
Indian J Pediat. 65:691–705. 1998. View Article : Google Scholar
|
|
8
|
Bessho F: Incidence of neuroblastoma.
Lancet. 353:701999. View Article : Google Scholar
|
|
9
|
Sridhar S, Al-Moallem B, Kamal H, Terrile
M and Stallings RL: New insights into the genetics of
neuroblastoma. Mol Diagn Ther. 17:63–69. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Crespo-Ortiz MP and Wei MQ: Antitumor
activity of artemisinin and its derivatives: from a well-known
antimalarial agent to a potential anti-cancer drug. J Biomed
Biotechnol. 2012:2475972012.PubMed/NCBI
|
|
11
|
Newman DJ and Cragg GM: Natural products
as sources of new drugs over the last 25 years. J Nat Prod.
70:461–477. 2007.PubMed/NCBI
|
|
12
|
Zhang YJ, Gallis B, Taya M, Wang S, Ho RJ
and Sasaki T: pH-responsive artemisinin derivatives and lipid
nanoparticle formulations inhibit growth of breast cancer cells in
vitro and induce down-regulation of HER family members. PloS One.
8:e590862013. View Article : Google Scholar
|
|
13
|
Miller LH and Su X: Artemisinin: discovery
from the Chinese herbal garden. Cell. 146:855–858. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sundar SN, Marconett CN, Doan VB,
Willoughby JA Sr and Firestone GL: Artemisinin selectively
decreases functional levels of estrogen receptor-alpha and ablates
estrogen-induced proliferation in human breast cancer cells.
Carcinogenesis. 29:2252–2258. 2008. View Article : Google Scholar
|
|
15
|
Duffy PE and Mutabingwa TK: Drug
combinations for malaria: time to ACT? Lancet. 363:3–4. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Willoughby JA Sr, Sundar SN, Cheung M, Tin
AS, Modiano J and Firestone GL: Artemisinin blocks prostate cancer
growth and cell cycle progression by disrupting Sp1 interactions
with the cyclin-dependent kinase-4 (CDK4) promoter and inhibiting
CDK4 gene expression. J Biol Chem. 284:2203–2213. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lai HC, Singh NP and Sasaki T: Development
of artemisinin compounds for cancer treatment. Invest New Drugs.
31:230–246. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tin AS, Sundar SN, Tran KQ, Park AH,
Poindexter KM and Firestone GL: Antiproliferative effects of
artemisinin on human breast cancer cells requires the downregulated
expression of the E2F1 transcription factor and loss of E2F1-target
cell cycle genes. Anticancer Drugs. 23:370–379. 2012. View Article : Google Scholar
|
|
19
|
Weifeng T, Feng S, Xiangji L, et al:
Artemisinin inhibits in vitro and in vivo invasion and metastasis
of human hepatocellular carcinoma cells. Phytomedicine. 18:158–162.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Reungpatthanaphong P and Mankhetkorn S:
Modulation of multidrug resistance by artemisinin, artesunate and
dihydroartemisinin in K562/adr and GLC4/adr resistant cell lines.
Biol Pharm Bull. 25:1555–1561. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yamachika E, Habte T and Oda D:
Artemisinin: an alternative treatment for oral squamous cell
carcinoma. Anticancer Res. 24:2153–2160. 2004.PubMed/NCBI
|
|
22
|
Cui H, Schroering A and Ding HF: p53
mediates DNA damaging drug-induced apoptosis through a
caspase-9-dependent pathway in SH-SY5Y neuroblastoma cells. Mol
Cancer Ther. 1:679–686. 2002.PubMed/NCBI
|
|
23
|
Lim S and Kaldis P: Cdks, cyclins and
CKIs: roles beyond cell cycle regulation. Development.
140:3079–3093. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lee IH and Finkel T: Metabolic regulation
of the cell cycle. Curr Opin Cell Biol. 25:724–729. 2013.
View Article : Google Scholar
|
|
25
|
Agrez M, Kovach J and Lieber M: Cell
aggregates in the soft agar ‘human tumour stem-cell assay’. Br J
Cancer. 46:8801982.
|
|
26
|
Youns M, Efferth T, Reichling J,
Fellenberg K, Bauer A and Hoheisel JD: Gene expression profiling
identifies novel key players involved in the cytotoxic effect of
Artesunate on pancreatic cancer cells. Biochem Pharmacol.
78:273–283. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li S, Xue F, Cheng Z, et al: Effect of
artesunate on inhibiting proliferation and inducing apoptosis of
SP2/0 myeloma cells through affecting NFkappaB p65. Int J Hematol.
90:513–521. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zeng Y, Ni X, Meng WT, Wen Q and Jia YQ:
Inhibitive effect of artesunate on human lymphoblastic
leukemia/lymphoma cells. Sichuan Da Xue Xue Bao Yi Xue Ban.
40:1038–1043. 2009.(In Chinese).
|
|
29
|
Zhou HJ, Wang WQ, Wu GD, Lee J and Li A:
Artesunate inhibits angiogenesis and downregulates vascular
endothelial growth factor expression in chronic myeloid leukemia
K562 cells. Vascul Pharmacol. 47:131–138. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li LN, Zhang HD, Yuan SJ, Yang DX, Wang L
and Sun ZX: Differential sensitivity of colorectal cancer cell
lines to artesunate is associated with expression of beta-catenin
and E-cadherin. Eur J Pharmacol. 588:1–8. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Rasheed SAK, Efferth T, Asangani IA and
Allgayer H: First evidence that the antimalarial drug artesunate
inhibits invasion and in vivo metastasis in lung cancer by
targeting essential extracellular proteases. Int J Cancer.
127:1475–1485. 2010. View Article : Google Scholar
|
|
32
|
Chaturvedi D, Goswami A, Saikia PP, Barua
NC and Rao PG: Artemisinin and its derivatives: a novel class of
anti-malarial and anticancer agents. Chem Soc Rev. 39:435–454.
2010. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Firestone GL and Sundar SN: Anticancer
activities of artemisinin and its bioactive derivatives. Expert Rev
Mol Med. 11:e322009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Efferth T, Sauerbrey A, Olbrich A, et al:
Molecular modes of action of artesunate in tumor cell lines. Mol
Pharmacol. 64:382–394. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xu Q, Li ZX, Peng HQ, et al: Artesunate
inhibits growth and induces apoptosis in human osteosarcoma HOS
cell line in vitro and in vivo. J Zhejiang Univ Sci B. 12:247–255.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Noori S, Hassan ZM and Farsam V:
Artemisinin as a Chinese medicine, selectively induces apoptosis in
pancreatic tumor cell line. Chin J Integr Med. Jun 15–2013.(Epub
ahead of print).
|
|
37
|
Xiao F, Gao W, Wang X and Chen T:
Amplification activation loop between caspase-8 and -9 dominates
artemisinin-induced apoptosis of ASTC-a-1 cells. Apoptosis.
17:600–611. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hou JM, Wang DS, Zhang RW and Wang H:
Experimental therapy of hepatoma with artemisinin and its
derivatives: In vitro and in vivo activity, chemosensitization, and
mechanisms of action. Clin Cancer Res. 14:5519–5530. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Gao W, Xiao F, Wang X and Chen T:
Artemisinin induces A549 cell apoptosis dominantly via a reactive
oxygen species-mediated amplification activation loop among
caspase-9, -8 and -3. Apoptosis. 18:1201–1213. 2013. View Article : Google Scholar : PubMed/NCBI
|
